PT Royal Prima Tbk (PRIM.JK)
IDR 57.0
(0.0%)
IDR 57.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -2.74 Billion IDR | -112.72% |
| 2022 | 21.58 Billion IDR | -71.38% |
| 2021 | 75.43 Billion IDR | 97.63% |
| 2020 | 38.16 Billion IDR | 1492.6% |
| 2019 | 2.39 Billion IDR | -86.07% |
| 2018 | 17.2 Billion IDR | -14.82% |
| 2017 | 20.19 Billion IDR | 74.96% |
| 2016 | 11.54 Billion IDR | 531.81% |
| 2015 | 1.82 Billion IDR | 179.31% |
| 2014 | -2.3 Billion IDR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -9.5 Billion IDR | -143.39% |
| 2024 Q3 | -4.56 Billion IDR | 51.93% |
| 2024 Q1 | -3.9 Billion IDR | -134.29% |
| 2023 Q4 | 11.38 Billion IDR | 2997.16% |
| 2023 FY | -2.74 Billion IDR | -112.72% |
| 2023 Q1 | -7.03 Billion IDR | -176.68% |
| 2023 Q3 | -392.96 Million IDR | 94.14% |
| 2023 Q2 | -6.7 Billion IDR | 4.68% |
| 2022 Q1 | 4.07 Billion IDR | 113.56% |
| 2022 Q3 | 1.85 Billion IDR | -71.37% |
| 2022 Q4 | 9.17 Billion IDR | 393.86% |
| 2022 FY | 21.58 Billion IDR | -71.38% |
| 2022 Q2 | 6.48 Billion IDR | 59.31% |
| 2021 FY | 75.43 Billion IDR | 97.63% |
| 2021 Q1 | 15.85 Billion IDR | -22.47% |
| 2021 Q2 | 47.28 Billion IDR | 198.28% |
| 2021 Q3 | 42.32 Billion IDR | -10.51% |
| 2021 Q4 | -30.02 Billion IDR | -170.96% |
| 2020 Q3 | 15.43 Billion IDR | 140251.3% |
| 2020 Q2 | -11.01 Million IDR | -100.48% |
| 2020 Q1 | 2.29 Billion IDR | 456.47% |
| 2020 FY | 38.16 Billion IDR | 1492.6% |
| 2020 Q4 | 20.44 Billion IDR | 32.5% |
| 2019 Q1 | 2.23 Billion IDR | -24.05% |
| 2019 FY | 2.39 Billion IDR | -86.07% |
| 2019 Q4 | 413.28 Million IDR | 1150.96% |
| 2019 Q3 | -39.32 Million IDR | 81.29% |
| 2019 Q2 | -210.16 Million IDR | -109.41% |
| 2018 FY | 17.2 Billion IDR | -14.82% |
| 2018 Q1 | 5.46 Billion IDR | 171.7% |
| 2018 Q2 | 2.69 Billion IDR | -50.69% |
| 2018 Q3 | 6.09 Billion IDR | 126.09% |
| 2018 Q4 | 2.93 Billion IDR | -51.79% |
| 2017 Q1 | 7.02 Billion IDR | 0.0% |
| 2017 Q4 | -7.62 Billion IDR | -155.38% |
| 2017 Q2 | 7.02 Billion IDR | -0.0% |
| 2017 Q3 | 13.77 Billion IDR | 96.05% |
| 2017 FY | 20.19 Billion IDR | 74.96% |
| 2016 FY | 11.54 Billion IDR | 531.81% |
| 2015 FY | 1.82 Billion IDR | 179.31% |
| 2014 FY | -2.3 Billion IDR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PT Bundamedik Tbk | 7.46 Billion IDR | 136.811% |
| PT Metro Healthcare Indonesia Tbk | -110.91 Billion IDR | 97.524% |
| PT Medikaloka Hermina Tbk | 437.34 Billion IDR | 100.628% |
| PT Mitra Keluarga Karyasehat Tbk | 916.13 Billion IDR | 100.3% |
| PT Murni Sadar Tbk | -12.83 Billion IDR | 78.596% |
| PT Famon Awal Bros Sedaya Tbk | 216.97 Billion IDR | 101.266% |
| PT Kedoya Adyaraya Tbk | 25.18 Billion IDR | 110.904% |
| PT Sarana Meditama Metropolitan Tbk | 12.25 Billion IDR | 122.416% |
| PT Siloam International Hospitals Tbk | 1211.28 Billion IDR | 100.227% |
| PT Sejahteraraya Anugrahjaya Tbk | -38.49 Billion IDR | 92.864% |